These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 27796748)

  • 1. Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View.
    Martin-Jiménez CA; Gaitán-Vaca DM; Echeverria V; González J; Barreto GE
    Mol Neurobiol; 2017 Nov; 54(9):7096-7115. PubMed ID: 27796748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?
    Kacířová M; Zmeškalová A; Kořínková L; Železná B; Kuneš J; Maletínská L
    Clin Sci (Lond); 2020 Mar; 134(5):547-570. PubMed ID: 32167154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases.
    McKenzie JA; Spielman LJ; Pointer CB; Lowry JR; Bajwa E; Lee CW; Klegeris A
    Curr Aging Sci; 2017; 10(3):158-176. PubMed ID: 28302047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration.
    Neal M; Richardson JR
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):432-443. PubMed ID: 29113750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
    Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling astrocytic contribution toward neurodegeneration with pluripotent stem cells: focus on Alzheimer's and Parkinson's diseases.
    Rinaldi F; Caldwell MA
    Neuroreport; 2013 Dec; 24(18):1053-7. PubMed ID: 24201446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aging immune system in Alzheimer's and Parkinson's diseases.
    Heavener KS; Bradshaw EM
    Semin Immunopathol; 2022 Sep; 44(5):649-657. PubMed ID: 35505128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
    Shacka JJ; Roth KA; Zhang J
    Front Biosci; 2008 Jan; 13():718-36. PubMed ID: 17981582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic pathways of locus coeruleus in Parkinson's and Alzheimer's pathology.
    Singh S
    Int J Neurosci; 2020 Mar; 130(3):251-261. PubMed ID: 31575316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.
    Montine TJ; Montine KS
    J Exp Med; 2015 May; 212(5):601-5. PubMed ID: 25941321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of mercury and arsenic in the etiology and pathogenesis of Parkinson's and Alzheimer's diseases].
    Salkov VN; Voronkov DN; Khudoerkov RM
    Arkh Patol; 2022; 84(5):59-64. PubMed ID: 36178224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes in physiological aging and Alzheimer's disease.
    Rodríguez-Arellano JJ; Parpura V; Zorec R; Verkhratsky A
    Neuroscience; 2016 May; 323():170-82. PubMed ID: 25595973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.
    Korecka JA; Verhaagen J; Hol EM
    Regen Med; 2007 Jul; 2(4):425-46. PubMed ID: 17635050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases.
    Wang Y; Yang Y; Zhang S; Li C; Zhang L
    Neurobiol Aging; 2020 Mar; 87():1-10. PubMed ID: 31986345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals.
    Sawikr Y; Yarla NS; Peluso I; Kamal MA; Aliev G; Bishayee A
    Adv Protein Chem Struct Biol; 2017; 108():33-57. PubMed ID: 28427563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease.
    Li C; Zhao R; Gao K; Wei Z; Yin MY; Lau LT; Chui D; Yu AC
    Curr Alzheimer Res; 2011 Feb; 8(1):67-80. PubMed ID: 21143158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Pathology and Electroencephalographic Activity in Parkinson's Disease.
    Caviness JN; Beach TG; Hentz JG; Shill HA; Driver-Dunckley ED; Adler CH
    Clin EEG Neurosci; 2018 Sep; 49(5):321-327. PubMed ID: 29161906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.